Estrella Immunopharma stock plunges in market debut after SPAC merger

seekingalpha2023-10-03

Shares of Estrella Immunopharma (ESLA) plunged 63% in their market debut following the biotech’s merger with SPAC TradeUp Acquisition Corp (NASDAQ:UPTD). Estrella shares opened at $5.21, hitting a ...

Source Link
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

Leave a comment
1
1